AU Stock MarketDetailed Quotes
PAAOA Neurizon Therapeutics Ltd
- 0.120
- 0.0000.00%
20min DelayMarket Closed Oct 14 16:00 AET
58.40MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.120Pre Close0.00Turnover0.32052wk High0.00%Turnover Ratio486.63MShares0.02852wk Low--EPS TTM43.26MFloat Cap0.320Historical High0.00P/E (Static)360.54MShs Float0.028Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Neurizon Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | -74.05%980.62K | -17.26%3.78M | 23.17%4.57M | -8.70%3.71M | -6.34%4.06M | 4.34M |
| Revenue from customers | -95.02%138.54K | -19.05%2.78M | 56.90%3.44M | -30.08%2.19M | -14.38%3.13M | --3.66M |
| Other cash income from operating activities | -15.40%842.08K | -11.83%995.37K | -25.56%1.13M | 63.51%1.52M | 37.15%927.52K | --676.3K |
| Cash paid | -15.57%-6.17M | 8.08%-5.34M | -25.58%-5.81M | 13.23%-4.63M | 9.00%-5.33M | -5.86M |
| Payments to suppliers for goods and services | -15.57%-6.17M | 8.08%-5.34M | -25.58%-5.81M | 13.23%-4.63M | 9.00%-5.33M | ---5.86M |
| Direct interest paid | ---- | 7.51%-81.86K | -167.41%-88.51K | -51.07%-33.1K | 54.19%-21.91K | ---47.82K |
| Direct interest received | -69.80%24.47K | 14,988.45%81.03K | -96.35%537 | -37.04%14.72K | 31.35%23.38K | --17.8K |
| Operating cash flow | -230.43%-5.17M | -17.41%-1.56M | -42.04%-1.33M | 26.14%-937.97K | 18.28%-1.27M | ---1.55M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -3,235.89%-1.17M | 19.48%-34.93K | 68.57%-43.38K | -356.64%-138.04K | 79.40%-30.23K | -146.73K |
| Net PPE purchase and sale | ---- | 19.86%-34.76K | 57.35%-43.38K | -236.49%-101.72K | 79.40%-30.23K | ---146.73K |
| Net intangibles purchas and sale | ---- | ---167 | ---- | ---36.32K | ---- | ---- |
| Net business purchase and sale | ---165.23K | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---1M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -3,235.89%-1.17M | 19.48%-34.93K | 68.57%-43.38K | -356.64%-138.04K | 79.40%-30.23K | ---146.73K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 606.14%13.34M | 145.07%1.89M | -36.58%770.99K | -41.83%1.22M | 9.09%2.09M | 1.92M |
| Net issuance payments of debt | ---- | -775.02%-354.33K | 116.37%52.49K | -9.08%-320.73K | -191.04%-294.03K | ---101.03K |
| Net common stock issuance | 493.06%13.31M | 212.29%2.24M | -53.24%718.5K | -35.55%1.54M | 18.20%2.38M | --2.02M |
| Net other financing activities | --35K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 606.14%13.34M | 145.07%1.89M | -36.58%770.99K | -41.83%1.22M | 9.09%2.09M | --1.92M |
| Net cash flow | ||||||
| Beginning cash position | 12.02%2.71M | -20.02%2.42M | 4.85%3.02M | 37.78%2.88M | 11.47%2.09M | --1.88M |
| Current changes in cash | 2,313.90%7.01M | 148.02%290.33K | -532.60%-604.65K | -82.30%139.77K | 267.05%789.87K | --215.19K |
| End cash Position | 258.99%9.71M | 12.02%2.71M | -20.02%2.42M | 4.85%3.02M | 37.78%2.88M | --2.09M |
| Free cash from | -223.22%-5.17M | -16.24%-1.6M | -27.85%-1.38M | 17.25%-1.08M | 23.55%-1.3M | ---1.7M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data